Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19602134 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Boceprevir-based Therapy to Rescue HCV Genotype 1/HBV Infected Patients Refractory to Combination Therapy
Condition: Hepatitis C, Chronic
Intervention: Drug: Stop trial intervention for boceprevir, PEG-IFN and RBV

Indicates status has not been verified in more than two years